AHRI Data Repository
Data Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / TASP / ANRS12249 / variable [F55]
tasp

Treatment as Prevention ANRS 12249, phase 1

South Africa, 2012 - 2014
Get Microdata
Reference ID
ANRS12249
Producer(s)
Dabis, François, Newell, Marie-Louise
Collections
TasP ANRS 12249
Metadata
Documentation in PDF DDI/XML JSON
Created on
May 06, 2014
Last modified
Jan 19, 2015
Page views
442269
Downloads
2222
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Related Publications
  • Data files
  • DBS Results
  • HIV Drug
    Treatments
  • Households
  • CBCs
  • CHEs
  • Lab Test
    Results
  • ARTemis Lab
    Results
  • ARTemis
    Patients
  • CHE Adverse
    Events
  • Specimens
  • Individual
    Consents
  • SCBs SCCs
  • iDART
  • CHE Action
    Plans
  • Locations
  • Clusters
  • Trial Statuses
  • Visits
  • HHIs
  • SCIs
  • CFUs
  • CFU Pill Tests
  • SAEs Initial
    Notifications
  • SAEs Initial
    Notifications -
    Events details
  • SAEs Initial
    Notifications -
    Medications
  • SAEs
    Complementary
    Notifications
  • SAEs
    Complementary
    Notifications -
    Medications
  • Individuals
  • IQs

According to the physician, is this SAE related to any causes other than the research? If yes, describe (SAECausedByOtherDesc)

Data file: SAEs Initial Notifications

Overview

Valid: 69
Type: Discrete
Width: 244
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
Abnormality present at baseline 1
1.4%
Accident 1
1.4%
Acute cholecystitis,abdonrmal liver function test was present prior to enrolment. 1
1.4%
Adequate information on circumstance of death not available. 1
1.4%
Advance HIV Multy-Drug resistant TB 1
1.4%
Advanced HIV 1
1.4%
Advanced HIV diseased with suspected pulmonary TB 1
1.4%
Advanced HW in patient who interrupted treatment on multiple occasion 1
1.4%
Alcohol abuse, present at baseline 1
1.4%
Anaemia of chronic decease 1
1.4%
Anemia of Chronic disease 1
1.4%
Baseline revealed Hepatitis BsAg positive . Further information not available 1
1.4%
CA Cervix predated enrolment in Trial 1
1.4%
Cellulitis present at baseline clinic visit 1
1.4%
Chronic GI Problem-need futher investigation (different diagnosis bowel TB,paitsistic infection malicvancy) 1
1.4%
Chronic lung deceases - Sequela of Previous TB decease 1
1.4%
Complication of breast feeding 1
1.4%
Diagnosis unknown . Patient has only been seen once at baseline . 1
1.4%
GGT started rising whilst patient was on D4T/3TC/EFV before joining the research . 1
1.4%
Gall stones 1
1.4%
Gastroenteritis 1
1.4%
HIV opportunistic inffection 1
1.4%
Had Menorrhagra dummy the last Menstrual period. 1
1.4%
High viral load despite prolong ARV use , amotype slims resistance to EFV and 3TC . 1
1.4%
History Incomplete 1
1.4%
Known HPT/CCF/Chronic renal failure 1
1.4%
LT Upper Zone PNeumonia , To Exclude Pulmonary TB Peptic ulcer disease . 1
1.4%
Likely to be worsering curonic kidney Disease due to Hypertension but coud Also be HIV - Associated Nepuropathy . 1
1.4%
Lower Respiratory Trect Infection 1
1.4%
Multiple ART defaults, cannot exlude bone narrow suppression from Cotrimaxazole 1
1.4%
Multy-Drug resistant treatment. 1
1.4%
Normocytic anaemia, requires further investigation. 1
1.4%
Patient ART naïve and not prescribed any drugs within trial 1
1.4%
Patient complained of weight loss and dry cough recently . 1
1.4%
Patient developes severe diarrhoea and Acute renal failure prior to Atripla Reveles by blood test done on same day started Atripla. Atripla could have exacerbated the acute renal failuere 1
1.4%
Patient must have suffered from dehydrated to vomiting exacerbated by tenofavir + hydrocithorothiazide 1
1.4%
Patient was already on antiretroviral drug before joining the research . 1
1.4%
Pelvic inflammatory disease 1
1.4%
Physical /Sexual Assault 1
1.4%
Pnevious TB Episodes ( 2007/2008 ) 1
1.4%
Poor adherence to ART mth multiple stops restarts possibly IRIS 1
1.4%
Possibly a combination of Stavudine treatment , Alcohol and Hepatitis B . 1
1.4%
Possibly related to Advanced HIV infection. Patient also anemic with weight loss. 1
1.4%
Pre - existing abnormality in YGT, Whilst on D4T/3TC/EFV. Need to obtain alcohol history. 1
1.4%
Predated the reseach . 1
1.4%
Probable Iron deficiency Anaemia 1
1.4%
Probable Pulmonary TB 1
1.4%
Probable iron Defigency Anaemia 1
1.4%
Probable iron deficiency.Anaemia 1
1.4%
Probably Haemorrhoids 1
1.4%
Probably alcohol abuse although HAART can cause elevate GT . 1
1.4%
Probably alcohol abuse. 1
1.4%
Probably alcohol related elevation of gamma glutamyl transference.Efavirenz was prescribed before participation in reseach. 1
1.4%
Probably iron deficientcy Anaemia 1
1.4%
Probably iron deficiency anaemia. 1
1.4%
Probably related to Alcohol abuse 1
1.4%
Pt had familly CD4 count and cough she may have had TB which was not investigated. She also had social stressor. 1
1.4%
Pulmonary TB 3
4.3%
Severe diarrhoea and renal failure pre - dated baseline clinic visit. Severe diarrhoea must have resulted in Pre renal failure with additional neuphrotixicty from Tinofavir 1
1.4%
Severe gastroenteritis resulting in acute renal failure exacerbated bytenofovir prescribed before joining trisil 1
1.4%
Stabbed abdomen 1
1.4%
Stroke 1
1.4%
Treatment interruption advanced HIV 1
1.4%
Unable to comment 1
1.4%
other differential diagnoses under investigation. Has risk factors for cerebral vascular disease 1
1.4%
severe hypochronic anemia 1
1.4%
unable to comment 1
1.4%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
AHRI Data Repository

© AHRI Data Repository, All Rights Reserved.